RankAlpha logo
Back to Rankings

LXEO

Lexeo TherapeuticsF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
9
U.S. public peers
Grade Position
Below peers
vs peer average
LXEO vs peer average
25/100
LXEO vs. peer average (F vs. C)
Grade spread
A 1 · B 2 · C 1 · D 2 · F 3
Graded peers loaded
Coverage
9 graded
100% of tracked

Peer overview

VYGR is the first available peer comparator.

Small-cap biotech with a single lead program; similar binary trial risk and sensitivity to financing outcomes.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerVYGRVoyager Therapeutics
LXEO
Lexeo Therapeutics
VYGR
Voyager Therapeutics
Grade
F
F
Momentum
8
31
Value
41
41
Sentiment
0
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs VYGR

LXEO / VYGR
Grade Position
Below peers
LXEO vs. peer average (F vs. C)
25/100
Momentum
8
VYGR
Value
41
LXEO
Sentiment
0
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs LXEO
1
VYGR
VYGR
F
20/100
Even
2
PBYI
Puma Biotechnology Inc Common
B
80/100
-3
3
GLSI
Greenwich LifeSciences Inc Common
B
80/100
-3
4
ENTA
Enanta Pharmaceuticals Inc Common
C
60/100
-2
5
LYEL
Lyell Immunopharma Inc Common
F
20/100
Even
VYGR is the first peer returned for this comparison set.